HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Kazuro Sugi Kimikazu Hamano Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sugi, K. Articles by Hamano, K. Search for Related Content PubMed PubMed Citation Articles by Sugi, K. Articles by Hamano, K. Related Collections Lung - cancer

J Thorac Cardiovasc Surg 2003;126:568-573
© 2003 The American Association for Thoracic Surgery

General thoracic surgery

Effect of radioisotope sentinel node mapping in patients with cT1 N0 M0 lung cancer

^a Department of Clinical Research, National Sanyo Hospital,, Ube, Yamaguchi, Japan
^b First Department of Surgery, Yamaguchi University School of Medicine, Ube, Yamaguchi, Japan

Received for publication December 6, 2002; revisions received February 7, 2003; revisions received February 28, 2003; accepted for publication April 8, 2003.

^* Address for reprints: Kazuro Sugi, MD, Department of Clinical Research, National Sanyo Hospital, Higashikiwa 685, Ube, Yamaguchi, 755-0241, Japan
ksugi{at}sanyou.hosp.go.jp

BACKGROUND: Application of the sentinel node concept to lung cancer is still controversial. Patients with peripheral small lung cancers would gain the most benefit from this concept, if it were valid. We sought to determine whether it is possible to choose between limited lymph node sampling and systematic lymphadenectomy from the distribution of sentinel lymph nodes in patients with node-negative disease on the basis of imaging.

METHODS: Sixty-five consecutive patients with cT1 N0 M0 non–small cell lung cancer were enrolled. A radioisotope tracer (4 mCi of technetium-99m tin colloid, 2.0 mL) was injected in the vicinity of the tumor before surgical intervention with computed tomographic guidance. The radioactivity of each resected lymph node was measured separately with a hand-held gamma probe after complete tumor resection. Sentinel nodes were identified, and the accuracy of sentinel node mapping was examined. Whether the location of the sentinel node depended on the site of the primary tumor was also examined.

RESULTS: Of the 65 patients, 3 were excluded because of the final pathologic results. Successful radionuclide migration occurred in 39 (62.9%) of the 62 patients. There was 1 (2.6%) false-negative result among 39 patients with a sentinel node, and therefore the sensitivity was 90%, and the specificity was 100%. The most common sentinel lymph nodes were at level 12 (46.7%), followed by level 11 (18.3%), the mediastinum (16.7%), and level 10 (11.7%).

CONCLUSION: The sentinel node concept is valid in patients with cT1 N0 M0 lung cancer. The lobar lymph nodes were identified as sentinel nodes more frequently than other lymph nodes. We need to make further efforts to increase the sentinel node identification rate. However, we believe that if sentinel nodes are identified, sentinel node mapping can allow the accurate intraoperative diagnosis of pathologic N0 status in patients with cT1 N0 M0 lung cancer.

Key Words: 10

This article has been cited by other articles:

				K. Sugi, S. Kobayashi, R. Yagi, and T. Matsuoka Usefulness of sentinel lymph node biopsy for the detection of lymph node micrometastasis in early lung cancer Interactive CardioVascular and Thoracic Surgery, October 1, 2008; 7(5): 913 - 915. [Abstract] [Full Text] [PDF]

				Y. Minamiya, M. Ito, Y. Hosono, H. Kawai, H. Saito, Y. Katayose, S. Motoyama, and J.-i. Ogawa Subpleural injection of tracer improves detection of mediastinal sentinel lymph nodes in non-small cell lung cancer Eur. J. Cardiothorac. Surg., November 1, 2007; 32(5): 770 - 775. [Abstract] [Full Text] [PDF]

				B. A. Whitson, S. S. Groth, and M. A. Maddaus Surgical Assessment and Intraoperative Management of Mediastinal Lymph Nodes in Non-Small Cell Lung Cancer Ann. Thorac. Surg., September 1, 2007; 84(3): 1059 - 1065. [Abstract] [Full Text] [PDF]

				H. Nomori, K. Ikeda, T. Mori, S. Shiraishi, H. Kobayashi, K. Iwatani, K. Kawanaka, and T. Kobayashi Sentinel node identification in clinical stage Ia non-small cell lung cancer by a combined single photon emission computed tomography/computed tomography system J. Thorac. Cardiovasc. Surg., July 1, 2007; 134(1): 182 - 187. [Abstract] [Full Text] [PDF]

				Y. Ohta, Y. Shimizu, H. Minato, I. Matsumoto, M. Oda, and G. Watanabe Results of Initial Operations in Non-Small Cell Lung Cancer Patients With Single-Level N2 Disease Ann. Thorac. Surg., February 1, 2006; 81(2): 427 - 433. [Abstract] [Full Text] [PDF]

				K. Ueda, Y. Kaneda, M. Sudo, M. Jinbo, K. Suga, and K. Hamono Cerebral Air Embolism During Imaging of a Sentinel Lymphatic Drainage in the Respiratory Tract Ann. Thorac. Surg., February 1, 2006; 81(2): 721 - 723. [Abstract] [Full Text] [PDF]

				Y. Minamiya, M. Ito, Y. Katayose, H. Saito, K. Imai, Y. Sato, and J.-i. Ogawa Intraoperative Sentinel Lymph Node Mapping Using a New Sterilizable Magnetometer in Patients with Nonsmall Cell Lung Cancer Ann. Thorac. Surg., January 1, 2006; 81(1): 327 - 330. [Abstract] [Full Text] [PDF]

				F. Puma Isolated mediastinal skip metastasis in lung cancer: Is it real N2 disease? J. Thorac. Cardiovasc. Surg., January 1, 2005; 129(1): 235 - 235. [Full Text] [PDF]